The Scleroderma Warriors Project is expanding its online presence with an updated website and…
Aisha I Abdullah PhD
Aisha Abdullah received a B.S. in biology from the University of Houston and a Ph.D. in neuroscience from Weill Cornell Medical College, where she studied the role of microRNA in embryonic and early postnatal brain development. Since finishing graduate school, she has worked as a science communicator making science accessible to broad audiences.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Aisha I Abdullah PhD
Chronic pain and impairment of the autonomic nervous system — which controls internal organs and regulates body processes…
Patients with scleroderma have poor core stability, as measured by trunk muscle strength…
The U.S. Food and Drug Administration (FDA) has accepted and granted priority review to an application for Esbriet (pirfenidone)…
In a study of the entire working population of Denmark, exposure to respirable crystalline silica — common in jobs…
A tiny RNA molecule called microRNA-320a is associated with regulating collagen levels and fibrosis, or scarring,…
More than 40% of scleroderma patients are diagnosed with osteopenia…
Lenabasum Eases Pulmonary Decline in dcSSc Patients on Long-term Immunosuppressants, Trial Finds
Updated results from the RESOLVE-1 Phase 3 clinical trial show that treatment with lenabasum reduces lung function decline in adults…
Genomic risk scores (GRS), which predict the likelihood of developing a condition based on a…
A Phase 1/2 clinical trial of FCX-013, Castle Creek Biosciences‘ experimental gene therapy for moderate to severe…